Compare ALTI & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALTI | RXST |
|---|---|---|
| Founded | 2020 | 1997 |
| Country | United States | United States |
| Employees | 490 | N/A |
| Industry | Investment Managers | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 412.6M | 305.0M |
| IPO Year | 2021 | 2021 |
| Metric | ALTI | RXST |
|---|---|---|
| Price | $3.86 | $7.12 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $9.78 |
| AVG Volume (30 Days) | 144.7K | ★ 685.7K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 41.11 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $254,956,000.00 | $134,479,000.00 |
| Revenue This Year | $18.06 | N/A |
| Revenue Next Year | $10.71 | $9.91 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 23.21 | N/A |
| 52 Week Low | $2.96 | $5.90 |
| 52 Week High | $5.45 | $16.73 |
| Indicator | ALTI | RXST |
|---|---|---|
| Relative Strength Index (RSI) | 51.85 | 50.77 |
| Support Level | $3.76 | $6.62 |
| Resistance Level | $3.92 | $9.11 |
| Average True Range (ATR) | 0.21 | 0.39 |
| MACD | 0.07 | 0.13 |
| Stochastic Oscillator | 81.33 | 85.97 |
AlTi Global Inc is a wealth and investment partner to families, foundations, and institutions, helping clients activate capital, bring structure to complexity, and plan across borders and generations. The company combines the breadth of an international firm with the service offering of a family office to deliver solutions for wealth and capital. It provides services including discretionary and non-discretionary investment advisory, estate and wealth planning, trust and fiduciary, governance, philanthropy, and family office services, along with access to alternative investment opportunities. The company generates revenue from management, advisory, trustee, or administration fees, performance or incentive fees, distributions from investments, and other income or fees.
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.